Upcoming Events
May 22 to May 23, 2024
Pharma Partnering Summit 2024

Basel, Switzerland

Past Events
May 12 to May 14, 2024
BioEquity

San Sebastian, Spain

Apr 11 to Apr 12, 2024
6th Early Access Programmes World Congress 2024 Europe

London, United Kingdom

Apr 11 to Apr 12, 2024
21st Orphan Drug & Rare Diseases Global Congress 2024 Europe

London, United Kingdom

Feb 26 to Feb 27, 2024
5th Patient Centricity & Collaboration World Congress

London, United Kingdom

Dec 9 to Dec 12, 2023
American Society of Hematology

San Diego, United States 

Dec 5 to Dec 6, 2023
Medinvest

Palo Alto 

Oct 30 to Nov 2, 2023
World Orphan Drug Congress

Barcelona, Spain 

Oct 19 to Oct 20, 2023
Pharma Partnering Summit

Boston, United States 

Jul 30 to Aug 4, 2023
Gordon Research Conference

West Dover, United States

Jun 21 to Jun 22, 2023
MedInvest

United States, Boston

Jun 8 to Jun 11, 2023
European Hematology Association

Frankfurt, Germany

Jun 1 to Jun 2, 2023
4th Patient Centricity & Collaboration World Congress 2023 Europe

London, United Kingdom

May 17 to May 18, 2023
13th Clinical Trials Strategic Summit

London, England

May 3 to May 4, 2023
LSX World Congress

London, England

Apr 6, 2023
Global Investor Forum

Rotterdam, Netherlands

Mar 29 to Apr 1, 2023
European Lung Cancer Congress 2023

Copenhagen, Denmark

Mar 14 to Mar 15, 2023
Advanced Therapies

London, England

Feb 28 to Mar 2, 2023
Biocom California's Global Life Science Partnering Conference

California, USA

Feb 5 to Feb 7, 2023
4th Scientific Workshop: the Haematological Tumour Microenvironment and its Therapeutic Targeting

London, England

Feb 4, 2023
World Cancer Day

It's time to raise awareness about cancer.



Dec 10 to Dec 13, 2022
ASH 2022

New Orleans, Louisiana

Nov 1 to Nov 3, 2022
CPHI 2022

Frankfurt, Germany 

Oct 10, 2022
DRUG REPURPOSING FOR RARE DISEASES

London, England

Sep 9 to Sep 13, 2022
ESMO 2022

Paris, France

Jun 23 to Jun 25, 2022
MASCC

Toronto, Canada

Jun 9 to Jun 12, 2022
European School of Hematology

Vienna , Austria

Jun 3 to Jun 7, 2022
ASCO 3-7 Jun Chicago

Chicago, USA

May 24 to May 25, 2022
Congress Advanced Therapies

Meet the team at Advanced Therapies in London 

Mar 30 to Apr 2, 2022
European Lung Cancer

Prague 

Mar 14 to Mar 15, 2022
ADVANCED THERAPIES 2023

London, England

Mar 11 to Mar 13, 2022
European School of Hematology

Budapest, Hungary
How to Treat AML SH 

Sep 21, 2021
Blood Cancer Awareness Month

Due to the rarity of the disease, data are lacking on the relationships between AML and most risk factors, and strong connections have not been made through epidemiological studies.

Sep 13, 2021
Blood Cancer Awareness Month

Secondary Acute Myeloid Leukaemia occurs more frequently in the elderly AML population than in younger patients and is typically more difficult to treat as it is less responsive to standard chemotherapies. 

Sep 7, 2021
Blood Cancer Awareness Month

The cause of AML is unknown; however, several risk factors have been associated with increased chance of developing AML, including, age, male sex, a history of smoking, and exposure to high doses of radiation and cytotoxic chemicals. 

Sep 2, 2021
Blood Cancer Awareness Month

Pleco’s team is working strenuously on the development of the PlecoidTM agents to increase the survival rate of patients with AML which is a disease carrying a poor prognosis.

Aug 1, 2021
World Lung Cancer

World Lung Cancer Day is taking place on the 1st of August 2021, PlecoTherapeutics is taking the opportunity to raise awareness to support patients and their families, especially those affected by Small Cell Lung Cancer (SCLC). 

Jun 16, 2021
Drug Repurposing for Rare Diseases 2021

Ivo Timmermans, Pleco’s CEO will be speaking at the Digital Conference Findacure’s annual Drug Repurposing Conference for RareDiseases on the 16th of June 2021. 

Jun 8, 2021
Ruffena Capital

Pleco Therapeutics’ CEO, Ivo Timmermans will present at the Investment Webinar organized by Ruffena Capital on the Tuesday 8th of June 2021 at 2pm.

Apr 21, 2021
KnowAML – KnowPlecoids World Awareness Day

Pleco Therapeutics aims to extend and enhance the lives of patients through its novel Plecoid therapies that increase the effectiveness of current cancer treatments.

Apr 15, 2021
Global Investor Forum 2021

Pleco is a proud finalist of Global Investor Forum 2021! Do you want to see us in the finale on 15 April during Innovation for Health?

Feb 1, 2021
Pleco team present at LSX World Congress

We are pleased to inform you that our board members Ivo Timmermans, Rudi Jansen and Gerben de Rijk will attend the 7th Annual LSX World Congress. This meeting will be delivered virtually, from 1 to 12 February

Feb 4, 2020
Events LSX World Congress in London

We are excited to share that our board members Ivo Timmermans and Rudi Jansen will attend the LSX World Congress in London. Our CEO Ivo Timmermans will give a presentation at the Biotech Showcase event

Nov 5 to Nov 7, 2019
CPHI Worldwide in Frankfurt

Our Chief Business Officer Rudi Jansen will be attending the Convention on Pharmaceutical Ingredients (CPHI Worldwide) in Frankfurt, Germany.